This hypothesis might have great impact considering ABCC6 as genetic modifier of other rare monogenic disorders (GACI), or common disease (stroke, myocardial infarction, and CAD). This evidence concerns the gene ABCC6 and arterial calcification, generalized, of infancy, 1.